🇺🇸 pentothal sodium in United States

13 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 13

Most-reported reactions

1. Blood Pressure Increased — 2 reports (15.38%)
2. Pleural Effusion — 2 reports (15.38%)
3. Renal Tubular Disorder — 2 reports (15.38%)
4. Accidental Overdose — 1 report (7.69%)
5. Airway Complication Of Anaesthesia — 1 report (7.69%)
6. Atrioventricular Block — 1 report (7.69%)
7. Crying — 1 report (7.69%)
8. Drug Hypersensitivity — 1 report (7.69%)
9. Electrocardiogram St Segment Depression — 1 report (7.69%)
10. Heart Rate Increased — 1 report (7.69%)

Source database →

Frequently asked questions

Is pentothal sodium approved in United States?

pentothal sodium does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for pentothal sodium in United States?

Ajou University School of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.